Abstract
We studied lysosomal Ca2+ in inflammasome. LPS+palmitic acid (PA) decreased lysosomal Ca2+ ([Ca2+]Lys) and increased [Ca2+]i through mitochondrial ROS, which was suppressed in Trpm2-KO macrophages. Inflammasome activation and metabolic inflammation in adipose tissue of high-fat diet (HFD)-fed mice were ameliorated by Trpm2 KO. ER→lysosome Ca2+ refilling occurred after lysosomal Ca2+ release whose blockade attenuated LPS+PA-induced inflammasome. Subsequently, store-operated Ca2+entry (SOCE) was activated whose inhibition suppressed inflammasome. SOCE was coupled with K+ efflux whose inhibition reduced ER Ca2+ content ([Ca2+]ER) and impaired [Ca2+]Lys recovery. LPS+PA activated KCa3.1 channel, a Ca2+-activated K+ channel. Inhibitors of KCa3.1 channel or Kcnn4 KO reduced [Ca2+]ER, attenuated increase of [Ca2+]i or inflammasome activation by LPS+PA, and ameliorated HFD-induced inflammasome or metabolic inflammation. Lysosomal Ca2+ release induced delayed JNK and ASC phosphorylation through CAMKII-ASK1. These results suggest a novel role of lysosomal Ca2+ release sustained by ER→lysosome Ca2+ refilling and K+ efflux through KCa3.1 channel in inflammasome activation and metabolic inflammation.
Competing Interest Statement
The authors have declared no competing interest.
Footnotes
1. Fig. 1D.: Since BAPTA-AM might affect transcription of pro-IL-1b,we have conducted immunoblot analysis after treatment with LPS+PA in the presence of BAPTA-AM. 2. Fig. 2-figure supplement 1A: To show expression of TRPM2 on lysosome, we conducted confocal microscopy after immunofluorescence staining using anti-TRMP2 and -LAMP2 antibodies. 3. Fig. 3-figure supplement 1A: To confirm that ACA is a TRPM2 inhibitor, we studied IL-1beta release by LPS+PA in the presence or absence of ACA.